Penicillium Chrysogenum Patents (Class 435/935)
  • Patent number: 8822163
    Abstract: Disclosed are a method for measuring ?G comprising the steps of bringing a sample into contact with a ?G-binding protein 1 and a ?G-binding protein 2, each comprising an amino acid sequence which is identical or substantially identical to an amino acid sequence shown in any one of SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:8, SEQ ID NO:10, SEQ ID NO:14, SEQ ID NO:16, SEQ ID NO:18, or SEQ ID NO:20, and having the ?-glucan binding activity, to form a complex of the ?G-binding protein 1, ?G in the sample and the ?G-binding protein 2, measuring quantity of the complex, and determining ?G concentration in the sample based on the quantity of the complex; a reagent and a kit for use in said method; a novel ?G-binding protein; a nucleic acid molecule encoding the ?G-binding protein; and a method for producing the aforementioned ?G-binding protein.
    Type: Grant
    Filed: March 17, 2010
    Date of Patent: September 2, 2014
    Assignee: Wako Pure Chemical Industries, Ltd.
    Inventor: Akito Yoneda
  • Patent number: 6787133
    Abstract: This invention provides purified telomerase and methods of purifying it. The methods involve the use of several sequential steps, including the use of matrices that bind molecules bearing negative charges, matrices that bind molecules bearing positive charges, intermediate-selectivity matrices, methods that separate molecules based on their size, shape, or buoyant density, and by affinity purification.
    Type: Grant
    Filed: December 24, 2002
    Date of Patent: September 7, 2004
    Assignee: Geron Corporation
    Inventors: Scott L. Weinrich, Edward M. Atkinson, III, Serge P. Lichtsteiner, Alain P. Vasserot, Ronald A. Pruzan
  • Patent number: 6410259
    Abstract: The present invention disclosures a process for the production of N-deacylated cephalosporin compounds via the fermentative production of their 7-acylated counterparts.
    Type: Grant
    Filed: August 26, 1999
    Date of Patent: June 25, 2002
    Assignee: DSM Patents & Trademarks
    Inventors: Maarten Nieboer, Erik De Vroom, Johannis Lugtenburg, Dirk Schipper, Adrianus Wilhelmus Hermanus Vollebregt, Roelof Ary Lans Bovenberg
  • Patent number: 6071713
    Abstract: A bioprocess for preparing adipoyl-7-ACA comprising the steps: (a) transforming cells of a strain of Penicillium chrysogenum which produces isopenicillin N with an expression vector containing DNA encoding an enzyme, having expandase activity capable of accepting adipoyl 6-APA as a substrate, an enzyme having hydroxylase activity capable of accepting adipoyl-7-ADCA as a substrate and an enzyme having acetyl transferase activity capable of accepting adipoyl 7-ADAC as a substrate; (b) culturing the transformed cells from step a) in a suitable culture medium containing an adipate feedstock, wherein said cells produce adipoyl 6-APA; and (c) culturing the transformed cells producing adipoyl 6-APA of step b) under conditions suitable for expression of said DNA encoding enzyme, thereby producing the end product adipoyl-7-ACA.
    Type: Grant
    Filed: June 28, 1999
    Date of Patent: June 6, 2000
    Assignee: Gist-Brocades B.V.
    Inventors: Michael J. Conder, John A. Rambosek, Phyllis C. McAda, Christopher D. Reeves
  • Patent number: 6017726
    Abstract: A process for making 7-aminodeacetyl-cephalosporanic acid (7-ADAC).
    Type: Grant
    Filed: April 17, 1997
    Date of Patent: January 25, 2000
    Assignee: Gist-Brocades B.V.
    Inventors: Michael J. Conder, John A. Rambosek, Phyllis C. McAda, Christopher D. Reeves
  • Patent number: 5882915
    Abstract: A process for producing strains of Trichoderma virens which are deficient for production of viridiol for use as biocontrol agents is disclosed. These mutant strains are produced by treatment of viable T. virens with chemical or physical mutagens, preferably by irradiation with ultraviolet light. The treated fungi are then screened for production of viridiol to select for deficient strains. Following recovery, the mutant strains may be used as biocontrol agents for the control of plant diseases by application to the locus of a plant, seedling or seed to be protected. Coating seeds with the biocontrol agent prior to planting has been found to be particularly effective for the control of soilborne root or seedling diseases.
    Type: Grant
    Filed: April 17, 1996
    Date of Patent: March 16, 1999
    Assignee: The United States of America as represented by the Secretary of Agriculture
    Inventor: Charles R. Howell
  • Patent number: 5874275
    Abstract: The present invention relates to polypeptides having mutanase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing the polypeptides. The present invention further relates to oral cavity compositions and methods for degrading mutan.
    Type: Grant
    Filed: October 22, 1997
    Date of Patent: February 23, 1999
    Assignees: Novo Nordisk A/S, Novo Nordisk Biotech, Inc.
    Inventors: Randy M Berka, Stephan Christgau, Torben Halkier, Jeff Shuster, Claus Crone Fuglsang
  • Patent number: 5328839
    Abstract: A new oxido reductase enzyme activity obtainable from P. chrysogenum, involved in the production of .beta.-lactams, the set of genes encoding said enzyme activity, and a method to enhance said production by using the above-mentioned oxido reductase system and other oxido reductase systems or genes encoding for the same have been disclosed.
    Type: Grant
    Filed: March 24, 1992
    Date of Patent: July 12, 1994
    Assignee: Gist-Brocades
    Inventors: Yair Aharonowitz, Lucia H. M. van der Voort, Gerald Cohen, Roelof A. L. Bovenberg, Rachel Schreiber, Anat Argaman, Yossef Av-Gay, Helena M. Nan, Alfred Kattevilder, Harriet Palissa, Henk van Liempt
  • Patent number: 5318896
    Abstract: An important intermediate for preparing cephalosporin antibiotics, 7-aminodesacetoxy cephalosporanic acid (7-ADCA), is prepared by a novel bioprocess in which a transformed Penicillium chrysogenum strain is cultured in the presence of an adipate feedstock to produce adipoyl-6-APA (6-amino penicillanic acid); and the in situ expression of an expandase gene, e.g., from Streptomyces clavuligerus, with which the P. chrysogenum has been transformed, converts the adipoly-6-APA by ring expansion to adipoyl-7-ADCA. The final product, 7-ADCA, is then prepared by cleavage of the adipoyl side chain using an adipoyl acylase. The entire synthesis, accordingly, is carried out using bioprocesses, and is efficient and economical.
    Type: Grant
    Filed: August 28, 1992
    Date of Patent: June 7, 1994
    Assignee: Merck & Co., Inc.
    Inventors: Michael J. Conder, Phyllis C. McAda, John A. Rambosek
  • Patent number: 5006471
    Abstract: A drug resistant strain of P.chrysogenum has said drug resistance conferred by heterologous DNA, in particular a heterologous gene(s) under the control of a Penicillium control sequence(s). Drug resistance is especially to sulfonamides, or to trimethoprim or methotrexate by a gene derived from plasmid R388. A vector capable of conferring resistance to methotrexate or sulfonamide on P.chrysogenum, comprises at least one said resistance gene under the control of trpC controlling sequences.
    Type: Grant
    Filed: March 26, 1987
    Date of Patent: April 9, 1991
    Assignee: Antibioticos S.A. of Bravo Murillo 38
    Inventors: Florentina S. Sanchez, Victor R. Susan, Laura Carramolino-Fitera, Agustin P. A. Ortega
  • Patent number: 4959327
    Abstract: Disclosed is a method for transforming Penicillium chrysogenum. More particularly, the method includes obtaining an auxotrophic mutant of P. chrysogenum and employing an exogeneous segment of P. chrysogenum DNA capable of complementing said auxotorph so as to restore prototrophy. The exogeneous DNA segment thus comprises a phenotypic marker indicating successful transformation of the mutant.The exogeneous complementary DNA segment may further be prepared in a recombinant plasmid vector. These plasmid vectors include, by way of example, the pPctrpCL and pPctrpC.sub.6 plasmids developed by Applicants. These transforming plasmid vectors and those having identifying characteristics thereof are suitable for use in the subject transformation process. The exogeneous complementary DNA segment comprises a gene encoding a selected biosynthetic enzyme. By way of example, these genes include trpC, pyr4, argB and NO.sup.- reductase, as well as other genes which encode metabolically required enzymes.
    Type: Grant
    Filed: February 2, 1987
    Date of Patent: September 25, 1990
    Assignee: Antibiotics, S.A.
    Inventors: Florentina S. Sanchez, Victor R. Susan, Miguel A. P. Soto, Agustin P. A. Ortega
  • Patent number: 4865973
    Abstract: A process for producing a variety of chemical products, e.g., ethanol, by fermentation in which the product is removed from the fermentation medium as it is formed by liquid-liquid extraction using an extractant for the product which is immiscible with water. The extractant employed is chosen from the following groups: (A) double bond unsaturated aliphatic alcohols having 12 or more carbon atoms; (B) saturated branched chain aliphatic alcohols having 14 or more carbon atoms or mixtures thereof; (C) double bond unsaturated aliphatic acids having 12 or more carbon atoms; (D) aliphatic and aromatic mono-, di- or tri-esters having 12 or more carbon atoms, other than dibutyl phthalate; (E) aliphatic noncyclic ketones and aliphatic aldehydes having 12 or more carbon atoms; and (F) mixtures of extractants from groups (A) to (E) above or mixtures of at least one of the above extractants and at least one other extractant.
    Type: Grant
    Filed: August 13, 1986
    Date of Patent: September 12, 1989
    Assignee: Queen's University at Kingston
    Inventors: Finn Kollerup, Andrew J. Daugulis
  • Patent number: 4749797
    Abstract: New tetra-alkyl-2,2,5,5-cyclohexanone-4-ol-1-compounds and their sulphonyl derivatives with the general formula: ##STR1## in which: each of R and R', identical or different, represents an alkyl radical (1-5 carbons) and R" represents a hydrogen atom or a radical SO.sub.2 R"' in which R"' represents an alkyl radical (1-5 carbons) or an aryl radical (6-14 carbons), the process and the intermediates for their preparation, as well as their use in the synthesis of cyclopropane lactones of cis structure.
    Type: Grant
    Filed: June 24, 1986
    Date of Patent: June 7, 1988
    Assignee: Roussel Uclaf
    Inventors: Jean D'Angelo, Gilbert Revial, Robert Azerad, Didier Buisson
  • Patent number: 4610826
    Type: Grant
    Filed: December 5, 1984
    Date of Patent: September 9, 1986
    Assignee: Roussel Uclaf
    Inventors: Jean D'Angelo, Gilbert Revial, Robert Azerad, Didier Buisson
  • Patent number: 4563419
    Abstract: This invention relates to a kit for the detection of microbial nucleic acids and a method for identifying the nucleic acids using a one-step sandwich hybridization technique. The technique requires two complementary nucleic acid reagents for each microbe or group of microbes to be identified.
    Type: Grant
    Filed: December 29, 1983
    Date of Patent: January 7, 1986
    Assignee: Orion Corporation Ltd.
    Inventors: Tuula M. Ranki, Hans E. Soderlund
  • Patent number: 4373026
    Abstract: A novel polyamine oxidase, polyamine oxidase PC-3, takes an important role participating in decomposition and metabolism and polyamines such as spermidine and spermine.
    Type: Grant
    Filed: December 12, 1980
    Date of Patent: February 8, 1983
    Assignee: Amano Pharmaceutical Co., Ltd.
    Inventors: Hideaki Yamada, Yoshiki Tani, Kimiyasu Isobe
  • Patent number: 4250258
    Abstract: Penicillin V is prepared by culturing a penicillin-producing microorganism in a medium containing suitable sources of nitrogen, carbon and energy, and inorganic salts. One or more phenoxyalkanes of the formula ##STR1## wherein n is an integer from 6 to 13 are included within the medium as the sidechain precursor.
    Type: Grant
    Filed: December 20, 1979
    Date of Patent: February 10, 1981
    Assignee: E. R. Squibb & Sons, Inc.
    Inventors: Laszlo J. Szarka, Robert W. Eltz
  • Patent number: 4200694
    Abstract: A novel pectin esterase which randomly hydrolyzes the methyl ester bond of pectin can be obtained by cultivating, on a medium, a mold strain belonging to Genus Aspergillus, Genus Penicillium, Genus Fusarium or Genus Sclerotinia and having an ability to produce said novel pectin esterase. A demethoxylated pectin having a uniform methoxyl group content can be obtained by adding said novel pectin esterase to pectin. The demethoxylated pectin thus obtained can be utilized as gelling agent, emulsifier or thickener for food processing.
    Type: Grant
    Filed: September 26, 1978
    Date of Patent: April 29, 1980
    Assignee: Kikkoman Shoyu Co., Ltd.
    Inventors: Shigetaka Ishii, Keiichi Kiho, Shinichi Sugiyama, Hiroshi Sugimoto
  • Patent number: 4164445
    Abstract: Ethanol is employed as the major source of carbon and energy in the fermentative biosynthesis of penicillins.
    Type: Grant
    Filed: March 27, 1975
    Date of Patent: August 14, 1979
    Assignee: E. R. Squibb & Sons, Inc.
    Inventors: Brian T. Sheehan, Judith Baymiller, Robert W. Eltz